{{Rsnum
|rsid=4627050
|Chromosome=11
|position=18800490
|Orientation=plus
|GMAF=0.3641
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.4 | 43.4 | 44.2
| HCB | 3.6 | 40.1 | 56.2
| JPT | 8.0 | 48.7 | 43.4
| YRI | 14.3 | 55.1 | 30.6
| ASW | 10.5 | 63.2 | 26.3
| CHB | 3.6 | 40.1 | 56.2
| CHD | 7.3 | 37.6 | 55.0
| GIH | 5.0 | 30.7 | 64.4
| LWK | 28.2 | 50.0 | 21.8
| MEX | 10.3 | 55.2 | 34.5
| MKK | 28.8 | 43.6 | 27.6
| TSI | 23.5 | 47.1 | 29.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=4E-6
  |OR=1.93
  |ORtxt=[1.452-2.572]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}